BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Talus Bioscience Enters Strategic Collaboration With PRISM BioLab To Unlock Transcription Driven Drug Targets

Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRI...

December 19, 2025 | News

Harbour BioMed Enters Global Antibody Collaboration With Bristol Myers Squibb

Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunolo...

December 18, 2025 | News

Eccogene Enrols First Patient In Phase 2a MOSAIC Trial For MASH Therapies

Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammato...

December 18, 2025 | News

Sanofi And Dren Bio Expand Strategic Collaboration To Advance Next Generation B Cell Depleting Therapies In Autoimmune Disease

– New collaboration builds on Sanofi’s prior acquisition of DR-0201 and further leverages Dren Bio’s proprietary Targeted Myeloid Engag...

December 17, 2025 | News

Thermo Fisher Scientific Advances Microbial Bioprocessing With Chemically Defined Media For Confident Plasmid DNA And Protein Scale Up

New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence Thermo Fisher Scientific In...

December 16, 2025 | News

Sobi To Acquire Arthrosi Therapeutics In Up To $1.5 Billion Deal

Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which w...

December 16, 2025 | News

Everest Medicines Enters Dual Strategic Agreements with Hasten to Drive Accretive Growth

- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveragi...

December 15, 2025 | News

ProPharma Advances Its India Growth Strategy With Hyderabad Expansion

ProPharma, the leading global provider of regulatory, clinical, and compliance services for the life sciences industry and a portfolio company of Ody...

December 12, 2025 | News

Formation Bio Acquires Global Rights To CNS Penetrant TYK2 Inhibitor LNK01006

Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals") and Formation Bio announced Formation Bio's acquisition of wor...

December 11, 2025 | News

D3 Bio Secures One Hundred 8M$ In Series B Funding To Advance Global Late Stage Oncology Trials

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completio...

December 11, 2025 | News

Cytiva And Fida Biosystems Partner To Strengthen Protein Interaction Analysis

Cytiva, a Danaher company and leader in the life sciences industry, and Fida Biosystems, a Danish company specializing in molecular analysis, have joined...

December 10, 2025 | News

Fosun Pharma And Pfizer Enter Global GLP One Receptor Agonist Licensing Deal For YP05002

Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Limited. ("Yao Pharma"), Shanghai Fosun Pharmaceutical Industrial Devel...

December 10, 2025 | News

ChemLex Establishes Global Headquarters And Self Driving Laboratory In Singapore With USD 45 Million Funding

ChemLex, a next-generation AI-for-science company,announced the establishment of its global headquarters and self-driving laboratory in Singapore, alo...

December 09, 2025 | News

GC Biopharma Ships World First Recombinant Anthrax Vaccine For National Stockpile

GC Biopharma (006280.KS), a leading global biopharmaceutical company, announced the first shipment of BARYTHRAX inj., the world's first recombinant a...

December 09, 2025 | News

Stay Connected